ArticleAdvanced biotechnology2026
Controllable nanotopography of lysine-branched self-assembling peptide hydrogels for tendon-bone insertion regeneration.
Article in Advanced biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Recent advances in tissue engineering have highlighted the critical roles of both mechanical and biochemical characteristics in tendon-bone insertion (TBI) regeneration. However, the influence of surface topography, particularly the development of biocompatible hydrogels with aligned nanotopographical structures while preserving intrinsic mechanical properties, remains insufficiently explored. Here, we engineered a lysine-branched self-assembling peptide hydrogels (Lys-SAPHs) to promote TBI healing. Compared with pristine SAPH, Lys-SAPHs exhibited distinctive aligned 3D groove-like topographies without compromising mechanical integrity or hemocompatibility. In vitro, Lys-SAPHs enhanced tendon stem cells (TSCs) and bone marrow mesenchymal stem cells (BMSCs) proliferation, migration, and tendonogenic differentiation, while promoting macrophage polarization toward a reparative M2 phenotype. In a rat TBI defect model, optimized Lys-SAPH (FEK17:FEK8 = 1:6) treatment facilitated superior tendon-bone regeneration, evidenced by reduced bone defect area on micro-CT, improved Achilles functional index (AFI), and increased fibrocartilage formation compared with SAPH and control groups. This study highlighted the critical role of nanotopography in directing stem cell fate and immune modulation and presented Lys-SAPHs as a versatile platform for designing next-generation self-assembling peptide hydrogels for tendon-bone repair and broader regenerative applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.